BankPlus Trust Department’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.76M Sell
26,466
-1,442
-5% -$320K 1.54% 7
2025
Q4
$6.38M Sell
27,908
-157
-0.6% -$35.8K 1.67% 8
2025
Q3
$6.5M Buy
28,065
+952
+4% +$194K 1.74% 7
2025
Q2
$5.03M Buy
27,113
+855
+3% +$159K 1.49% 8
2025
Q1
$5.5M Buy
26,258
+34
+0.1% +$6.61K 1.84% 8
2024
Q4
$4.66M Buy
+26,224
New +$4.82M 1.53% 8

Other funds holding ABBV

BankPlus Trust Department's ABBV Position: Q1 2026 in Review

BankPlus Trust Department reduced its AbbVie (ABBV) stake by 5.2% in Q1 2026, selling an estimated $320K and leaving 26,466 shares worth $5.76M. The position accounts for 1.54% of the portfolio, ranked #7.

BankPlus Trust Department first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.5M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • BankPlus Trust Department held 26,466 shares of AbbVie worth $5.76M as of Q1 2026.
  • BankPlus Trust Department sold 1,442 AbbVie shares in Q1 2026, an estimated $320K.
  • AbbVie made up 1.54% of BankPlus Trust Department's portfolio in Q1 2026, its #7 holding.
  • BankPlus Trust Department first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • BankPlus Trust Department's AbbVie position peaked at $6.5M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on BankPlus Trust Department's 13F filing for Q1 2026, filed 11 May 2026.